A comparison of the miotic and inflammatory effects of biologically active polypeptides and prostaglandin E2 on the rabbit eye.
D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D004600:Eledoisin / Q000031:analogs & derivatives / Q000494:pharmacology; D005123:Eye / Q000187:drug effects*; D007249:Inflammation / Q000188:drug therapy; D007429:Intraocular Pressure / Q000187:drug effects; D008916:Miotics / Q000494:pharmacology; D010446:Peptide Fragments / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology* / Q000627:therapeutic use; D010909:Pituitary Hormones, Posterior / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits; D013004:Somatostatin / Q000494:pharmacology; D013373:Substance P / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
D008916:Miotics; D010446:Peptide Fragments; D010455:Peptides; D010909:Pituitary Hormones, Posterior; D011458:Prostaglandins E; C019092:substance P analog(eledoisin related peptide); D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D013004:Somatostatin; C032682:substance P (4-11); D004600:Eledoisin; C000498:coherin; D001920:Bradykinin